Concepts (52)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Deoxycytidine | 3 | 2017 | 45 | 0.960 |
Why?
|
| Pancreatic Neoplasms | 3 | 2017 | 354 | 0.820 |
Why?
|
| Antimetabolites, Antineoplastic | 2 | 2017 | 42 | 0.520 |
Why?
|
| Calcium Channel Agonists | 1 | 2017 | 11 | 0.510 |
Why?
|
| Calcitriol | 1 | 2017 | 25 | 0.500 |
Why?
|
| Antibiotics, Antineoplastic | 2 | 2005 | 38 | 0.430 |
Why?
|
| Tamoxifen | 2 | 2005 | 42 | 0.430 |
Why?
|
| Doxorubicin | 2 | 2005 | 98 | 0.420 |
Why?
|
| Carrier Proteins | 1 | 2017 | 716 | 0.360 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2017 | 211 | 0.220 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2005 | 38 | 0.220 |
Why?
|
| Amlodipine | 1 | 2004 | 2 | 0.220 |
Why?
|
| Estrogen Antagonists | 1 | 2004 | 16 | 0.210 |
Why?
|
| Calcium Channel Blockers | 1 | 2004 | 58 | 0.210 |
Why?
|
| Adenosine Triphosphatases | 2 | 2017 | 256 | 0.200 |
Why?
|
| Cell Survival | 2 | 2017 | 588 | 0.200 |
Why?
|
| Cell Line, Tumor | 3 | 2017 | 1566 | 0.190 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2017 | 583 | 0.190 |
Why?
|
| Drug Synergism | 2 | 2017 | 142 | 0.150 |
Why?
|
| Butylated Hydroxyanisole | 1 | 2017 | 2 | 0.130 |
Why?
|
| Butylated Hydroxytoluene | 1 | 2017 | 4 | 0.130 |
Why?
|
| Silymarin | 1 | 2017 | 3 | 0.130 |
Why?
|
| Cell-Derived Microparticles | 1 | 2016 | 6 | 0.120 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2016 | 218 | 0.110 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2015 | 223 | 0.100 |
Why?
|
| Blotting, Western | 1 | 2015 | 611 | 0.100 |
Why?
|
| Cell Death | 1 | 2015 | 288 | 0.100 |
Why?
|
| Kinetics | 1 | 2015 | 757 | 0.100 |
Why?
|
| Cell Membrane | 1 | 2015 | 506 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 643 | 0.080 |
Why?
|
| Models, Biological | 2 | 2005 | 1192 | 0.070 |
Why?
|
| RNA, Messenger | 1 | 2015 | 1575 | 0.070 |
Why?
|
| Time Factors | 1 | 2015 | 3771 | 0.060 |
Why?
|
| Calcium-Transporting ATPases | 1 | 2005 | 7 | 0.060 |
Why?
|
| Bile | 1 | 2005 | 19 | 0.060 |
Why?
|
| Area Under Curve | 1 | 2005 | 148 | 0.060 |
Why?
|
| Caco-2 Cells | 1 | 2004 | 67 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2005 | 624 | 0.050 |
Why?
|
| Humans | 4 | 2017 | 65385 | 0.050 |
Why?
|
| Myocardium | 1 | 2005 | 302 | 0.050 |
Why?
|
| Kidney | 1 | 2005 | 454 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 857 | 0.050 |
Why?
|
| Rats | 1 | 2005 | 1995 | 0.040 |
Why?
|
| Liver | 1 | 2005 | 870 | 0.040 |
Why?
|
| Neoplasm Transplantation | 1 | 2016 | 167 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2016 | 287 | 0.030 |
Why?
|
| Tumor Microenvironment | 1 | 2016 | 183 | 0.030 |
Why?
|
| Animals | 2 | 2016 | 21356 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2016 | 1038 | 0.020 |
Why?
|
| Apoptosis | 1 | 2016 | 1098 | 0.020 |
Why?
|
| Male | 2 | 2016 | 31147 | 0.020 |
Why?
|
| Mice | 1 | 2016 | 11125 | 0.010 |
Why?
|